Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan

被引：23
|
作者：
Hiramatsu, Yukihiro [1 ]
Miyaji, Yusuke [1 ,2 ]
Otsuka, Nao [1 ]
Arakawa, Yoshichika [3 ]
Shibayama, Keigo [1 ]
Kamachi, Kazunari [1 ]
机构：
[1] Natl Inst Infect Dis, Tokyo, Japan
[2] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan
[3] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
来源：
EMERGING INFECTIOUS DISEASES | 2017年 / 23卷 / 04期
关键词：
EUROPEAN COUNTRIES; UNITED-STATES; FITNESS; STRAINS; VACCINE;
D O I：
10.3201/eid2304.161575
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Prevalence of pertactin-lacking Bordetella pertussis isolates has been observed worldwide. In Japan, however, we found that the frequency of pertactin-deficient isolates in 2014-2016 (8%) was significantly lower than the frequency in 2005-2007 (41%), 2008-2010 (35%), and 2011-2013 (25%). This reduction was closely associated with changes in genotypes.
引用
收藏
页码：699 / 701
页数：3
相关论文
共 50 条
  • [41] Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland
    Barkoff, Alex-Mikael
    Mertsola, Jussi
    Guillot, Sophie
    Guiso, Nicole
    Berbers, Guy
    He, Qiushui
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (10) : 1703 - 1704
  • [42] Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003
    Shane Byrne
    Andrew T Slack
    BMC Infectious Diseases, 6
  • [43] Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan
    Han, Hyun-Ja
    Kamachi, Kazunari
    Okada, Kenji
    Tbyoizumi-Ajisaka, Hiromi
    Sasaki, Yuko
    Arakawa, Yoshichika
    VACCINE, 2008, 26 (12) : 1530 - 1534
  • [44] Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity
    King, AJ
    Berbers, G
    van Oirschot, HFLM
    Hoogerhout, P
    Knipping, K
    Mooi, FR
    MICROBIOLOGY-SGM, 2001, 147 : 2885 - 2895
  • [45] Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin
    Hijnen, Marcel
    He, Qiushui
    Schepp, Rutger
    Van Gageldonk, Pieter
    Mertsola, Jussi
    Mooi, Frits R.
    Berbers, Guy A. M.
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (02) : 94 - 104
  • [46] A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells
    Stefanelli, Paola
    Fazio, Cecilia
    Fedele, Giorgio
    Spensieri, Fabiana
    Ausiello, Clara Maria
    Mastrantonio, Paola
    NEW MICROBIOLOGICA, 2009, 32 (02): : 159 - 166
  • [47] Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis
    Li, Zenglan
    Zhang, Yan
    Wang, Qi
    Li, Zhengjun
    Liu, Yongdong
    Zhang, Songping
    Zhang, Guifeng
    Ma, Guanghui
    Luo, Jian
    Su, Zhiguo
    VACCINE, 2016, 34 (34) : 4032 - 4039
  • [48] Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica (vol 68, pg 4815, 2000)
    Boursaux-Eude, C
    Guiso, N
    INFECTION AND IMMUNITY, 2000, 68 (12) : 7214 - 7214
  • [49] Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003
    Byrne, S
    Slack, AT
    BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [50] Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
    Martin, Stacey W.
    Pawloski, Lucia
    Williams, Margaret
    Weening, Keeley
    DeBolt, Chas
    Qin, Xuan
    Reynolds, Laura
    Kenyon, Cynthia
    Giambrone, Gregory
    Kudish, Kathy
    Miller, Lisa
    Selvage, David
    Lee, Adria
    Skoff, Tami H.
    Kamiya, Hajime
    Cassiday, Pamela K.
    Tondella, Maria L.
    Clark, Thomas A.
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) : 223 - 227
12345